|
|
||||||||
Corrigendum |
a Department of Cardiothoracic Surgery, James Cook University Hospital, Middlesbrough, UK
b Department of Cardiothoracic Surgery, Leiden University Medical Center, Leiden, Netherlands
c Department of Cardiac Surgery, Vicenzo Hospital, Italy
d Institute of Cardiology, La Pitié-Salpêtriére Hospital, Paris, France
e Department of Cardiothoracic Surgery, University Hospital of Liege, Liege, Belgium
f Department of Cardiothoracic Surgery, Karolinska University Hospital, Stockholm, Sweden
g Department of Cardiothoracic Surgery, Papworth Hospital, CB23 3RE, Cambridge, UK
* Corresponding author. Tel.: +44 1480 364299; fax: +44 1480 364744. (Email: sam.nashef{at}papworth.nhs.uk).
The authors regret that in the above article there was an error on page 86, left hand column, Section 11: Antiplatelet management for patients after cardiac surgery, paragraph 3, line 4.
Of note there was no evidence of a higher rate of GI and bleeding complications in the non-aspirin group.
Should read
Of note they also found a higher rate of GI and bleeding complications in the non-aspirin group.
The authors apologise for this oversight.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |